Hydroxocobalamin Injection shortage
Current 2 presentations · 2 manufacturers · first FDA posting 2024-11-04 · last update 2026-10-15
Manufacturers: BTG International Inc., Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) | BTG International Inc. | Current Limited Availability |
Other | Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage. | Posted 11/04/2024 Updated 10/01/2026 |
| Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30) | Teva Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: mid-November 2026 | Posted 11/04/2024 Updated 10/15/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)